ITLN1 and breast cancer: Broaden the research scope to include more metabolic factors associated markers, such as lipocalins (43) or hypoxia inducible factor-1 (44) SNPs in relation to DNA damage with ITLN1 and CD295 in BC in either obese or insulin resistance, pre-diabetic patients.